Paton D J, Füssel A-E, Vosloo W, Dekker A, De Clercq K
The Pirbright Institute, Ash Road, Woking GU24 0NF, Surrey, UK.
DG SANCO/G2, Rue Froissart 101-3/67, B-1040 Brussels, Belgium.
Vaccine. 2014 Dec 12;32(52):7050-6. doi: 10.1016/j.vaccine.2014.10.064. Epub 2014 Nov 5.
To eliminate incursions of foot-and-mouth disease (FMD) quickly, a combination of measures, including emergency vaccination, can help block the spread of infection. For the earliest recovery of the FMD-free status for trade, without the slaughter of uninfected vaccinated animals, a serosurvey for antibodies to FMD virus non-structural proteins (NSP) must be used to substantiate absence of occult virus infections. Areas of doubt over requirements for post-vaccination serosurveillance and its feasibility include the required and achievable confidence, the amount of sampling necessary, and the appropriate responses to and consequences of different seropositive findings. This derives largely from uncertainty over the extent of localised pockets of virus infection that may remain within vaccinated populations and the circumstances that permit this. The question therefore remains whether tests are sufficiently sensitive and specific to detect and eliminate infected animals, without excessive culling of uninfected animals, before vaccinated animals mix with non-vaccinated livestock when movement restrictions are lifted. It is recommended to change the rationale for serosurveillance after emergency vaccination. Only when emergency vaccination is used in limited outbreaks is it possible to test and cull comprehensively, an approach compatible with a three-month minimum period to recover the FMD-free status. In other situations, where emergency vaccination is used, such as dealing with large outbreaks in animal-dense regions and where the onset of vaccination has been delayed, post-vaccination serosurveys should be targeted and focus on providing an assurance to detect higher levels of infection, in case of inadequate control measures. As this provides less assurance of absence of infection, the approach would be compatible with a six-month waiting period for free-status recovery and should be complemented by other methods to provide evidence that vaccination and control measures have been effectively implemented, as these are the best guarantee against continuing virus transmission.
为了迅速消除口蹄疫(FMD)的入侵,包括紧急接种疫苗在内的一系列措施有助于阻止感染的传播。为了在不屠宰未感染的接种动物的情况下,最早恢复无口蹄疫状态以进行贸易,必须使用对口蹄疫病毒非结构蛋白(NSP)抗体进行血清学调查,以证实不存在隐匿性病毒感染。关于疫苗接种后血清学监测的要求及其可行性存在疑问的方面包括所需的和可实现的置信度、必要的采样量,以及对不同血清学阳性结果的适当应对措施和后果。这在很大程度上源于对可能存在于接种动物群体中的局部病毒感染范围以及允许这种情况发生的环境的不确定性。因此,问题仍然是,在解除行动限制后,接种动物与未接种牲畜混群之前,检测方法是否足够灵敏和特异,能够检测并清除感染动物,同时又不会过度扑杀未感染动物。建议改变紧急接种疫苗后血清学监测的基本原理。只有在有限的疫情爆发中使用紧急接种疫苗时,才有可能进行全面检测和扑杀,这种方法与恢复无口蹄疫状态的最短三个月期限相一致。在其他使用紧急接种疫苗的情况下,例如应对动物密集地区的大规模疫情爆发以及接种疫苗开始时间延迟的情况,疫苗接种后的血清学调查应具有针对性,重点是确保能够检测到更高水平的感染,以防控制措施不力。由于这种方法对不存在感染的保证较少,因此该方法与恢复无疫状态的六个月等待期相一致,并且应该辅以其他方法,以证明疫苗接种和控制措施已经有效实施,因为这些是防止病毒持续传播的最佳保障。